CANCER RISK FROM AZATHIOPRINE IN INFLAMMATORY BOWEL-DISEASE

CANCER RISK FROM AZATHIOPRINE IN INFLAMMATORY BOWEL-DISEASE

Bibliographic Details
Main Authors:	Connell, W, Kinlen, L, Ritchie, J, Balkwill, A, Lennardjones, J, Kamm, M
Format:	Journal article
Published:	1994

Similar Items

Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine.
by: Fraser, A, et al.
Published: (2002)

CYCLOPHOSPHAMIDE, AZATHIOPRINE, AND MALIGNANCY
by: Kinlen, L
Published: (1977)

Increased incidence of azathioprine-induced toxicity in inflammatory bowel diseases compared to other diseases
by: Weersma, R, et al.
Published: (2004)

The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.
by: Fraser, A, et al.
Published: (2002)

Analysis of the NUDT15 gene and metabolites of azathioprine in Japanese patients with inflammatory bowel disease
by: Shizuka Suzuki, et al.
Published: (2023-07-01)

Long‐term safety and effectiveness of azathioprine in the management of inflammatory bowel disease: A real‐world experience
by: Rohan V Yewale, et al.
Published: (2023-09-01)

DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease
by: Davide Selvestrel, et al.
Published: (2023-01-01)

The impact of glutathione S–transferase genotype and phenotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases
by: Hui Liu, et al.
Published: (2015-10-01)

Trend towards dose reduction of azathioprine as monotherapy in inflammatory bowel disease patients: what about for combination therapy?
by: Nicolas Williet, et al.
Published: (2017-01-01)

The Inflammatory Bowel Disease Drug Azathioprine Induces Autophagy via mTORC1 and the Unfolded Protein Response Sensor PERK
by: Hooper, K, et al.
Published: (2019)

Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease
by: Slavica Lazarević, et al.
Published: (2022-04-01)

Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis.
by: Campbell, A, et al.
Published: (1976)

Risks and benefits of azathioprine therapy.
by: McGovern, D, et al.
Published: (2005)

Association of genetic polymorphism of NUDT15, TPMT and ITPA gene in the toxicity and efficacy of azathioprine-based regimen in Egyptian inflammatory bowel disease patients
by: Nashwa Eltantawy, et al.
Published: (2023-01-01)

Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients
by: Tong Li, et al.
Published: (2020-11-01)

Systematic review: Pelvic floor muscle training for functional bowel symptoms in inflammatory bowel disease
by: Angela J Khera, et al.
Published: (2019-12-01)

Azathioprine and Steroids
by: Knight, SR, et al.
Published: (2008)

Infection and cancer - Reply
by: Kinlen, L, et al.
Published: (2001)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
by: Elsone, L, et al.
Published: (2012)

Inflammatory bowel disease and the risk of fracture.
by: van Staa, T, et al.
Published: (2003)

INFLAMMATORY BOWEL DISEASE AND THE RISK OF FRACTURE
by: Arden, N, et al.
Published: (2003)

Inflammatory bowel disease and the risk of fracture
by: van Staa, T, et al.
Published: (2002)

Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease
by: Gian Paolo Caviglia, et al.
Published: (2021-07-01)

Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease
by: Wael El-Matary, et al.
Published: (2020-07-01)

Azathioprine in ulcerative colitis.
by: Jewell, D, et al.
Published: (1972)

6-Mercaptopurine Or Azathioprine?
by: McGovern, D, et al.
Published: (2007)

Azathioprine, cyclophosphamide and chlorambucil.
by: Luqmani, R, et al.
Published: (1990)

Prevalence of mental health disorders in inflammatory bowel disease: an Australian outpatient cohort
by: Tribbick D, et al.
Published: (2015-07-01)

Azathioprine Hypersensitivity Syndrome: Two Cases of Febrile Neutrophilic Dermatosis Induced by Azathioprine
by: Majed Aleissa, et al.
Published: (2017-01-01)

Serum Inflammatory Markers and Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases
by: Ananthakrishnan, Ashwin N., et al.
Published: (2016)

Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
by: Francisco Mesonero, et al.
Published: (2024-03-01)

Inflammatory bowel disease and the risk of fracture
by: van Staa, T, et al.
Published: (2003)

Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient Management
by: Viviana Laredo, et al.
Published: (2023-01-01)

Adalimumab and azathioprine in the prevention of postoperative crohn’s disease recurrence
by: A. V. Poletova, et al.
Published: (2020-10-01)

New treatments and azathioprine in multiple sclerosis.
by: Palace, J, et al.
Published: (1997)

Frailty in inflammatory bowel diseases: an emerging concept
by: Bharati Kochar, et al.
Published: (2021-09-01)

Breast cancer and month of birth.
by: Balkwill, A, et al.
Published: (1987)

Redox imbalance in Crohn's disease patients is modulated by Azathioprine
by: Mohammad Javad Tavassolifar, et al.
Published: (2021-01-01)

Genetics of inflammatory bowel disease and associated cancers
by: Leedham, S, et al.
Published: (2006)

Infliximab and azathioprine: bridge or parachute?
by: Travis, S
Published: (2006)